Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Other Working Capital Changes (2016 - 2020)

Historic Other Working Capital Changes for Forte Biosciences (FBRX) over the last 5 years, with Q4 2020 value amounting to -$59000.0.

  • Forte Biosciences' Other Working Capital Changes fell 27878.79% to -$59000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $263000.0, marking a year-over-year increase of 886666.67%. This contributed to the annual value of $1.4 million for FY2024, which is 6171.97% up from last year.
  • Latest data reveals that Forte Biosciences reported Other Working Capital Changes of -$59000.0 as of Q4 2020, which was down 27878.79% from $1.7 million recorded in Q3 2020.
  • In the past 5 years, Forte Biosciences' Other Working Capital Changes registered a high of $2.2 million during Q3 2018, and its lowest value of -$2.8 million during Q4 2018.
  • For the 5-year period, Forte Biosciences' Other Working Capital Changes averaged around $101550.0, with its median value being $142000.0 (2019).
  • As far as peak fluctuations go, Forte Biosciences' Other Working Capital Changes tumbled by 59136.44% in 2018, and later surged by 1076875.0% in 2020.
  • Forte Biosciences' Other Working Capital Changes (Quarter) stood at -$219000.0 in 2016, then surged by 364.38% to $579000.0 in 2017, then tumbled by 591.36% to -$2.8 million in 2018, then soared by 101.16% to $33000.0 in 2019, then tumbled by 278.79% to -$59000.0 in 2020.
  • Its Other Working Capital Changes was -$59000.0 in Q4 2020, compared to $1.7 million in Q3 2020 and -$1.7 million in Q2 2020.